Intensive Course in Controlled Substance Prescribing: Pain, Anxiety, Insomnia is organized by Case Western Reserve University (CWRU) School of Medicine and will be held from Feb 11 - 13, 2019 at George S. Dively Conference Center, Cleveland, Ohio, United States of America.
The target audience for this medical event are basically is physicians in all specialties who need or wish to increase their knowledge and ability to effectively prescribe controlled medications that have abuse potential. In addition, the course is designed for physicians who treat chronic pain syndromes. This CME conference has been approved for a maximum of 24.50 AMA PRA Category 1 Credits.
Controlled substances are prescribed and dispensed today at an increasing rate to help patients cope with pain, insomnia, anxiety, depression, ADHD, and a myriad of other disorders. Studies show that most practitioners are rather conservative when prescribing controlled drugs while a small number are at times overly aggressive. In addition, controlled prescription medications are falling into the hands of increasing numbers of prescription drug abusers.
How can the practitioner more effectively understand the pharmacologic profiles for controlled drugs, identify diagnostic criteria for appropriate prescribing, and consider the therapeutic implications of specific substance use by individual patients? This special intensive course has been developed to enhance the physician’s ability to effectively prescribe controlled medications, while minimizing their misuse whenever possible.
After attending this course, participants will be able to:
• Describe the pharmacologic profiles of benzodiazepines, opiates and other controlled drugs
• Identify the diagnostic criteria and management strategies for acute and chronic pain, anxiety disorder, insomnia, depression and substance abuse
• Employ interviewing techniques relating to the diagnosis and management of substance abuse in general and prescription drug abusers in particular
• Discuss case management strategies for the above diagnoses
• Discuss beliefs, stereotypes, and attitudes about controlled substance prescribing, controlled drug abusers and chemical dependency, and consider the therapeutic implications of treatments based upon these beliefs
• List the special clinical requirements necessary when prescribing controlled drugs
Additional details will be posted as soon as they are available.
|Contact No. :||216.368.2000
Conference Fee Details
|Conference Fee||:||USD $1600.00|
|Early Fee Last date||:||NA|